Advances in Adult Asthma Diagnosis Treatment and HCEDQ in 2008

摘要

In 2008 the Journal reported new findings in management of asthma. Dosing schedules of inhaled steroids have been modified and individualized. New more costly propellants are replacing ozone-depleting chlorofluorocarbons. An association of asthma with pneumococcal disease has been observed. Smoking bans in public places are eliminating second-hand smoke and reducing asthma-related ED visits among adults. In contrast to these advances, however, disparity in asthma morbidity persists: blacks compared with whites have a 4-fold greater risk of an asthma-related ED visit.